Sciubba Daniel M, Lin Li-Mei, Woodworth Graeme F, McGirt Matthew J, Carson Benjamin, Jallo George I
Department of Neurosurgery, Baltimore, Maryland 21287, USA.
Neurosurg Focus. 2007 Apr 15;22(4):E9. doi: 10.3171/foc.2007.22.4.11.
Antibiotic-impregnated shunt (AIS) systems may decrease the incidence of cerebrospinal fluid (CSF) shunt infections. However, there is a reluctance to use AIS components because of their increased cost. In the present study the authors evaluated factors contributing to the medical costs associated with the treatment of CSF shunt infections in a hydrocephalic pediatric population, those implanted with AIS systems compared with those implanted with standard shunt systems.
The authors retrospectively reviewed data obtained in all pediatric patients who had undergone CSF shunt insertion at their institution over a 3-year period. All patients were followed up for 12 months after surgery. The independent association between AIS catheter use and subsequent shunt infection was assessed by performing a multivariate proportional hazards regression analysis. Factors contributing to the medical costs associated with shunt infection were evaluated.
Two hundred eleven pediatric patients underwent 353 shunting procedures. Two hundred eight shunts (59%) were placed with nonimpregnated catheters and 145 shunts (41%) were placed with AIS catheters. Twenty-five patients (12%) with non-AIS catheters experienced shunt infection, whereas only two patients (1.4%) with AIS catheters had a shunt infection within the 6-month follow-up period (p < 0.01). Among infected patients, infected patients with standard shunt components had a longer average hospital stay, more inpatient complications related to infection treatment, and more multiple organism infections and multiple antibiotic regimens, compared with those with AIS components.
Although individual AIS components are more expensive than standard ones, factors contributing to medical costs are fewer in pediatric patients with infected shunts when the components are antibiotic-impregnated rather than standard.
抗生素浸渍分流(AIS)系统可能会降低脑脊液(CSF)分流感染的发生率。然而,由于成本增加,人们不愿使用AIS组件。在本研究中,作者评估了在小儿脑积水患者中,与CSF分流感染治疗相关的医疗成本的影响因素,比较了植入AIS系统的患者和植入标准分流系统的患者。
作者回顾性分析了在3年期间在其机构接受CSF分流置入术的所有儿科患者的数据。所有患者术后随访12个月。通过进行多变量比例风险回归分析,评估使用AIS导管与随后分流感染之间的独立关联。评估了与分流感染相关的医疗成本的影响因素。
211名儿科患者接受了353次分流手术。208根分流管(59%)使用的是非浸渍导管,145根分流管(41%)使用的是AIS导管。25名(12%)使用非AIS导管的患者发生了分流感染,而在6个月随访期内,只有2名(1.4%)使用AIS导管的患者发生了分流感染(p<0.01)。在感染患者中,与使用AIS组件的患者相比,使用标准分流组件的感染患者平均住院时间更长,与感染治疗相关的住院并发症更多,多重微生物感染和多种抗生素治疗方案更多。
虽然单个AIS组件比标准组件更昂贵,但对于分流感染的儿科患者,当组件为抗生素浸渍而非标准组件时,导致医疗成本的因素更少。